Multicenter comparative study of conventional mechanical gas ventilation to tidal liquid ventilation in oleic acid injured sheep

ASAIO Journal

Volumn 54, Issue 3, 2008, Pages 256-269

  Wolfson, Marla R ^a   Hirschl, Ronald B ^b   Jackson, J Craig ^c   Gauvin, France ^c   Foley, David S ^b   Lamm, Wayne J E ^a   Gaughan, John ^a   Shaffer, Thomas H ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LUNG INJURY; AIRWAY PRESSURES; CARDIAC OUTPUT; COMPARATIVE STUDIES; EFFICIENCY INDEX; EXPANSION INDEX; GAS EXCHANGE; INTERLEUKIN-6; INTERLEUKIN-8; LIQUID VENTILATIONS; LUNG INJURY; MULTICENTER STUDY; MYELOPEROXIDASE; OXYGEN DELIVERY; OXYGEN SATURATION; PLASMA LACTATE; STROKE VOLUMES; TREATMENT GROUP; VENTILATOR SYSTEMS;

ACIDS; ANIMALS; LIQUIDS; MERCURY (METAL); OLEIC ACID; OXYGEN; VENTILATION; WOOL;

BIOLOGICAL ORGANS;

INTERLEUKIN 6; INTERLEUKIN 8; LACTIC ACID; MYELOPEROXIDASE; OLEIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN TENSION; ARTICLE; ARTIFICIAL VENTILATION; CARBON DIOXIDE TENSION; CARDIOPULMONARY FUNCTION; CONTROLLED STUDY; GAS EXCHANGE; GAS VENTILATION; HEART OUTPUT; HEART STROKE VOLUME; INTERMETHOD COMPARISON; LACTATE BLOOD LEVEL; LIQUID VENTILATION; LUNG ALVEOLUS; LUNG COMPLIANCE; LUNG INJURY; LUNG MINUTE VOLUME; LUNG PRESSURE; NONHUMAN; SHEEP; VENOUS OXYGEN TENSION; ANIMAL; BREATHING MECHANICS; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; EVALUATION; HEMODYNAMICS; INFLAMMATION; INJURY; LUNG; MULTICENTER STUDY; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; HEMODYNAMICS; INFLAMMATION; LIQUID VENTILATION; LUNG; OLEIC ACID; RESPIRATION, ARTIFICIAL; RESPIRATORY MECHANICS; SHEEP;

EID: 46249117880     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e318168fef0     Document Type: Article

References (77)

1. Slutsky AS, Tremblay LN: Multiple system organ failure. Is mechanical ventilation a contributing factor? Am J Respir Crit Care Med 157: 1721-1725, 1998.
2. The Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342: 1301-1308, 2000.
3. de Durante G, del Turco M, Rustichini L, et al: ARDSNet lower tidal volume ventilatory strategy may generate intrinsic positive end-expiratory pressure in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 165: 1271-1274, 2002.
4. Shaffer TH, Moskowitz GD: Demand-controlled liquid ventilation of the lungs. J Appl Physiol 36: 208-213, 1974.
5. Shaffer TH, Rubenstein D, Moskowitz D, Delivoria-Papadopoulos M: Gaseous exchange and acid-base balance in premature lambs during liquid ventilation since birth. Pediatr Res 10: 227-231, 1976.
6. Wolfson MR, Tran N, Bhutani VK, Shaffer TH: A new experimental approach for the study of cardiopulmonary physiology during early development. J Appl Physiol 65: 1436-1443, 1988.
7. Wolfson MR, Greenspan JS, Deoras KS, et al: Comparison of gas and liquid ventilation: Clinical, physiological, and histological correlates. J Appl Physiol 72: 1024-1031, 1992.
8. Wolfson MR, Stern RG, Kechner N, et al: Utility of a perfluorochemical liquid for pulmonary diagnostic imaging. Art Cells Blood Subs Immob Biotech 22: 1409-1420, 1994.
9. Hirschl RB, Parent A, Tooley R, et al: Lung management with perfluorocarbon liquid ventilation improves pulmonary function and gas exchange during extracorporeal membrane oxygenation (ECMO). Art Cells Blood Subs Immob Biotech 22: 1389-1396, 1994.
10. Hirschl RB, Overbeck MC, Parent A, et al: Liquid ventilation provides uniform distribution of perfluorocarbon in the setting of respiratory failure. Surgery 116: 159-167, 1994.
11. Wolfson MR, Greenspan JS, Shaffer TH: Pulmonary administration of vasoactive substances by perfluorochemical ventilation. Pediatrics 97: 449-455, 1996.
12. Greenspan JS, Wolfson MR, Rubenstein SD, Shaffer TH: Liquid ventilation of preterm baby [letter]. Lancet 2: 1095, 1989.
13. Shaffer TH, Foust R, Wolfson MR, Miller TF Jr: Analysis of perfluorochemical elimination from the respiratory system. J Appl Physiol 83: 1033-1040, 1997.
14. Mazzoni M, Nugent L, Klein D, et al: Dose monitoring in partial liquid ventilation by infrared measurement of expired perfluorochemicals. Biomed Instrum Tech 33: 356-364, 1999.
15. Hirschl RB, Pranikoff T, Gauger P, et al: Liquid ventilation in adults, children, and full-term neonates. The Lancet 346: 1201-1202, 1995.
16. Leach CL, Greenspan JS, Rubenstein SD, et al; The LiquiVent Study Group: Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. N Engl J Med 335: 761-767, 1996.
17. Kacmarek RM, Wiedemann HP, Lavin PT, et al: Partial liquid ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 173: 882-889, 2006.
18. Sekins KM, Nugent L, Mazzoni M, et al: Recent innovations in total liquid ventilation system and component design. Biomed Instrum Tech 33: 277-284, 1999.
19. Shashikant BN, Miller TL, Welch RW, et al: Dose response to rhCC10-augmented surfactant therapy in a lamb model of infant respiratory distress syndrome: Physiologic, inflammatory and kinetic profiles. J Appl Physiol 99: 2204-2211, 2005.
20. Schierwagen C, Bylung-Fellenjus AA, Lunberg C: An improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity. J Pharmacol Meth 23: 174-186, 1990.
21. Deoras KS, Wolfson MR, Searls RL, et al: Use of a touch sensitive screen and computer assisted image analysis for quantitation of developmental changes in pulmonary structure. Pediatr Pulmonol 9: 109-118, 1990.
22. Rubenfeld GD, Caldwell E, Peabody E, et al: Incidence and outcomes of acute lung injury. N Engl J Med 353: 1685-1693, 2005.
23. Perkins GD, McAuley DF, Thickett DR, Gao F: The beta-agonist lung injury trial (BALTI): A randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 173: 281-287, 2006.
24. Brun-Buisson C, Minelli C, Bertolini G, et al: Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med 30: 51-61, 2004.
25. Kylstra JA, Paganelli CV, Lanphier EH: Pulmonary gas exchange in dogs ventilated with hyperbarically oxygenated liquid. J Appl Physiol 21: 177-184, 1966.
26. Clark LC Jr, Gollan F: Survival of mammals breathing breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science 152: 1755-1756, 1966.
27. Wolfson MR, Shaffer TH: Liquid ventilation: An adjunct for respiratory management. Paediatric Anaesthesia 14: 15-23, 2004.
28. Winslow RM: Blood substitutes. Curr Opin Hematol 9: 146-151, 2002.
29. Brazitikos PD, Androudi S, D'Amico DJ, et al: Perfluorocarbon liquid utilization in primary vitrectomy repair of retinal detachment with multiple breaks. Retina 23: 615-621, 2003.
30. Hirschl RB, Philip WF, Glick L, et al: A prospective, randomized pilot trial of perfluorocarbon-induced lung growth in newborns with congenital diaphragmatic hernia. J Pediatr Surg 38: 283-289, 2003.
31. Cohen JL, Cheirif J, Segar DS, et al: Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent.Results of a phase III Multicenter Trial. J Am Coll Cardiol 32: 746-752, 1998.
32. Anderson CM, Brown JJ, Balfe DM, et al: MR imaging of Crohn disease: Use of perflubron as a gastrointestinal contrast agent. J Magn Reson Imaging 4: 491-496, 1994.
33. Kurki TS, Harjula AL, Heikkila LJ, et al: Single-lung allotransplantation in pigs: Effects of two preservation methods on pulmonary gas exchange. J Heart Transplant 9: 424-428, 1990.
34. Calderwood HW, Ruiz BC, Tham MK, et al: Residual levels and biochemical changes after ventilation with perfluorinated liquid. J Appl Physiol 39: 603-607, 1975.
35. Weinberger D, Goldenbergcohen N, Axersiegel R, et al: Long term follow-up of perfluorocabon liquid in the anterior chamber. Retina: J Retin Vitreous Dis 18: 233-237, 1998.
36. Hood CI, Modell JH: A morphologic study of long-term retention of fluorocarbon after liquid ventilation. Chest 118: 1436-1440, 2000.
37. Holaday DA, Fiserova-Bergerova V, Modell JH: Uptake, distribution, and excretion of fluorocarbon FX-80 (perfluorobutyl perfluorotetrahydrofuran) during liquid breathing in the dog. Anesthesiology 37: 387-394, 1972.
38. Cox CA, Stavis L, Wolfson MR, Shaffer TH: Long-term tidal liquid ventilation in premature lambs: Physiologic, biochemical and histological correlates. Biol Neonate 84: 232-242, 2003.
39. Reickert C, Pranikoff T, Overbeck M, et al: The pulmonary and systemic distribution and elimination of perflubron from adult patients treated with partial liquid ventilation. Chest 119: 515-522, 2001.
40. Gross GW, Greenspan JS, Fox WW, et al: Use of liquid ventilation with perflubron during extracorporeal membrane oxygenation: Chest radiographic appearances. Radiology 194: 717-720, 1995.
41. Blinder KJ, Peyman GA, Desai UR, et al: Vitreon, a short-term vitreoretinal tamponade. Br J Ophthalmol 76: 525-528, 1992.
42. Noveck RJ, Shannon EJ, Leese PT, et al: Randomized safety studies of intravenous perflubron emulsion. II. Effects on immune function in healthy volunteers. Anesth Analg 91: 812-822, 2000.
43. Hirschl RB, Pranikoff T, Gauger P, et al: Liquid ventilation in adults, children, and full-term neonates. Lancet 346: 1201-1202, 1995.
44. Hirschl RB, Pranikoff T, Wise C, et al: Initial experience with partial liquid ventilation in adult patients with the acute respiratory distress syndrome. JAMA 275: 383-389, 1996.
45. Gauger PG, Pranikoff T, Schreiner RJ, et al: Initial experience with partial liquid ventilation in pediatric patients with the acute respiratory distress syndrome. Crit Care Med 24: 16-22, 1996.
46. Hirschl RB, Croce M, Gore D, et al: Prospective, randomized, controlled pilot study of partial liquid ventilation in adult acute respiratory distress syndrome. Am J Resp Crit Care Med 165: 781-787, 2002.
47. Miller TF, Milestone BN, Stern RG, et al: Effect of single versus multiple dosing on perfluorochemical distribution and elimination profile during partial liquid ventilation. Pediatr Pulmonol 27: 410-418, 1999.
48. Meinhardt JP, Quintel M, Hirschl RB: Development and application of a double-piston configured, total-liquid ventilatory support device. Crit Care Med 28: 1483-1488, 2000.
49. Baba Y, Taenaka Y, Akagi H, et al: A volume-controlled liquid ventilator with pressure-limit mode: Imperative expiratory control. Artif Organs 20: 1052-1056, 1996.
50. Curtis SE, Fuhrman BP, Howland DF, et al: Cardiac output during liquid (perfluorocarbon) breathing in newborn piglets. Crit Care Med 19: 225-230, 1991.
51. Jackson JC, Standaert TA, Truog WE, Hodson WA: Full-tidal liquid ventilation with perfluorocarbon for prevention of lung injury in newborn non-human primates. Art Cells Blood Subs Immob Biotech 22: 1121-1132, 1994.
52. Degraeuwe PL, Vos GD, Geskens GG, et al: Effect of perfluorochemical liquid ventilation on cardiac output and blood pressure variability in neonatal piglets with respiratory insufficiency. Pediatr Pulmonol 30: 114-124, 2000.
53. Foust R, Kechner NK, Wolfson MR, Shaffer TH: Comparison of gas ventilation and PFC ventilation in acute meconium lung injury. Faseb J 7: A230, 1993.
54. Cox CA, Fox WW, Weiss CM, et al: Liquid ventilation: Gas exchange, perfluorochemical uptake, and biodistribution in an acute lung injury. Pediatr Crit Care Med 3: 288-296, 2002.
55. Hirschl RB, Merz SI, Montoya JP, et al: Development and application of a simplified liquid ventilator. Crit Care Med 23: 157-163, 1995.
56. Heckman JL, Hoffman J, Shaffer TH, Wolfson MR: Software for real-time control of a tidal liquid ventilator. Biomedl Instrum Tech 33: 268-276, 1999.
57. Degraeuwe PL, Dohmen LR, Geilen JM, Blanco CE: A feedback controller for the maintenance of FRC during tidal liquid ventilation: Theory, implementation, and testing. Int J Artif Organs 23: 680-688, 2000.
58. Corno C, Fiore GB, Martelli E, et al: Volume controlled apparatus for neonatal tidal liquid ventilation. ASAIO J 49: 250-258, 2003.
59. Tredici S, Komori E, Funakubo A, et al: A prototype of a liquid ventilator using a novel hollow-fiber oxygenator in a rabbit model. Critl Care Med 32: 2104-9, 2004.
60. Libros R, Philips CM, Wolfson MR, Shaffer TH: A perfluorochemical loss/restoration (L/R) system for tidal liquid ventilation. Biomed Instrum Technol 34: 351-360, 2000.
61. Webb HH, Tierney DF: Experimental pulmonary edema due to intermittent positive pressure ventilation with high inflation pressures. Protection by positive end-expiratory pressure. Am Rev Respir Dis 110: 556-565, 1974.
62. Dreyfuss D, Basset G, Soler P, Saumon G: Intermittent positivepressure hyperventilation with high inflation pressures produces pulmonary microvascular injury in rats. Am Rev Respir Dis 132: 880-884, 1985.
63. Kolobow T, Moretti MP, Fumagalli R, et al: Severe impairment in lung function induced by high peak airway pressure during mechanical ventilation. An experimental study. Am Rev Respir Dis 135: 312-315, 1987.
64. Parker JC, Townsley MI, Rippe B, et al: Increased microvascular permeability in dog lungs due to high peak airway pressures. J Appl Physiol 57: 1809-1816, 1984.
65. Lachmann B, Danzmann E, Haendly B, Jonson B: Ventilatory settings and gas exchange in respiratory distress syndrome, in Prakash O (ed), Applied Physiology in Clinical Care. The Hague, Elsevier, 141-176, 1982.
66. Lachmann B: Open up the lung and keep the lung open. Intensive Care Med 18: 319-321, 1992.
67. Amato MB, Barbas CS, Medeiros DM, et al: Effect of a protectiveventilation strategy on mortality in the acute respiratory distress syndrome [see comments]. New Eng J Med 338: 347-354, 1998.
68. Villar J, Kacmarek RM, Perez-Mendez L, Aguirre-Jaime A: A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: A randomized controlled trial. Crit Care Med 34: 1311-1318, 2006.
69. Koen PA, Wolfson MR, Shaffer TH: Fluorocarbon ventilation: Maximal expiratory flows and CO2 elimination. Pediatr Res 24: 291-296, 1988.
70. Tarczy-Hornoch P, Hildebrandt J, Jackson JC: Gravitational effects on volume distribution in a model of partial and total liquid ventilation. Respir Physiol 120: 125-138, 2000.
71. Lowe C, Tuma RF, Sivieri EM, Shaffer TH: Liquid ventilation: Cardiovascular adjustments with secondary hyperlactatemia and acidosis. J Appl Physiol: Respir Environ Exerc Physiol 47: 1051-1057, 1979.
72. Vincent JL, Sakr Y, Ranieri VM: Epidemiology and outcome of acute respiratory failure in intensive care unit patients. Crit Care Med 31: S296-S299, 2003.
73. Meduri GU, Kohler G, Headley S, et al: Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 108: 1303-1314, 1995.
74. Ranieri M, Suter PM, Tortorella C, et al: Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: A randomized controlled trial. JAMA 282: 54-61, 1999.
75. Ranieri VM, Giunta F, Suter PM, Slutsky A: Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome. JAMA 284: 43-44, 2000.
76. Stuber F, Wrigge H, Schroeder S, et al: Kinetic and reversibility of mechanical ventilation-associated pulmonary and systemic inflammatory responses in patients with acute lung injury. Intensive Care Med 28: 834-841, 2002.
77. Jiang L, Wang Q, Liu Y, et al: Total liquid ventilation reduces lung injury in piglets after cardiopulmonary bypass. Ann Thorac Surg 82: 124-130, 2006.